- Home
- HOWL vs SFWL Comparison
HOWL vs SFWL Comparison
Compare HOWL & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- SFWL
- Stock Information
- Founded
- HOWL 2017
- SFWL 2001
- Country
- HOWL United States
- SFWL China
- Employees
- HOWL N/A
- SFWL N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- SFWL Trucking Freight/Courier Services
- Sector
- HOWL Health Care
- SFWL Industrials
- Exchange
- HOWL Nasdaq
- SFWL Nasdaq
- Market Cap
- HOWL 53.4M
- SFWL 81.0M
- IPO Year
- HOWL 2021
- SFWL 2023
- Fundamental
- Price
- HOWL $1.25
- SFWL $1.00
- Analyst Decision
- HOWL Strong Buy
- SFWL
- Analyst Count
- HOWL 3
- SFWL 0
- Target Price
- HOWL $8.33
- SFWL N/A
- AVG Volume (30 Days)
- HOWL 549.8K
- SFWL 10.8K
- Earning Date
- HOWL 08-07-2025
- SFWL 09-04-2025
- Dividend Yield
- HOWL N/A
- SFWL N/A
- EPS Growth
- HOWL N/A
- SFWL 4.79
- EPS
- HOWL N/A
- SFWL 0.13
- Revenue
- HOWL $1,143,000.00
- SFWL $504,158,000.00
- Revenue This Year
- HOWL N/A
- SFWL N/A
- Revenue Next Year
- HOWL N/A
- SFWL N/A
- P/E Ratio
- HOWL N/A
- SFWL $7.65
- Revenue Growth
- HOWL N/A
- SFWL 24.75
- 52 Week Low
- HOWL $0.60
- SFWL $0.86
- 52 Week High
- HOWL $4.18
- SFWL $1.60
- Technical
- Relative Strength Index (RSI)
- HOWL 45.36
- SFWL 54.48
- Support Level
- HOWL $1.03
- SFWL $0.96
- Resistance Level
- HOWL $1.10
- SFWL $1.02
- Average True Range (ATR)
- HOWL 0.07
- SFWL 0.05
- MACD
- HOWL -0.02
- SFWL 0.00
- Stochastic Oscillator
- HOWL 22.81
- SFWL 90.91
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.